Page 122 - NMD-Report-59

ó) ¤ÅѧàÀÊѪÀѳ±ì
- ÃÒ¡Ò÷èÃѺ¢鹺ѭª ¨Ó¹Ç¹ ô,÷øø ÃÒ¡ÒÃ
ÁÙŤèÒ ôõó,ôõñ,öòñ.ðø ºÒ·
- ÃÒ¡Ò÷è¨èÒÂãËé˹èÇÂàºÔ¡ ¨Ó¹Ç¹ ó,óøó ÃÒ¡ÒÃ
ÁÙŤèÒ ôôù,ø÷ò,ðñù.ó÷ ºÒ·
ô) á¼¹¡ºÃÔ¡ÒÃàÀÊѪ¡ÃÃÁ¼Ùé»èÇÂã¹
- ¡ÒèèÒÂÂÒã¹áÅй͡àÇÅÒÃÒª¡Òà ¨Ó¹Ç¹ óø,÷óù ¤ÃÑé§

- ãºÊÑè§ÂÒ ¨Ó¹Ç¹ òõö,õðò ãº
- â¤Ã§¡ÒúÃÔºÒżÙé»èÇÂÃѺÂÒ Warfarin ¨Ó¹Ç¹ ñöö ÃÒÂ
- â¤Ã§¡ÒúÃÔºÒżÙé»èÇÂâä ACS ¨Ó¹Ç¹ ñòó ÃÒÂ
- â¤Ã§¡ÒúÃÔºÒżÙé»èÇÂâäÇѳâä ¨Ó¹Ç¹ òôð ÃÒÂ
õ) á¼¹¡ºÃÔ¡ÒÃàÀÊѪ¡ÃÃÁ¼Ùé»èǹ͡
- ʶԵÔãºÊÑè§ÂÒ¼Ùé»èÇÂã¹áÅй͡àÇÅÒÃÒª¡Òà ¨Ó¹Ç¹ óð÷,õ÷ø ãº
- §Ò¹â¤Ã§¡Òà Drug Deliverִ ¨Ó¹Ç¹ ÷,ðóó ãº
- â¤Ã§¡ÒúÃÔºÒżÙé»èÇÂÃѺÂÒ Warfarin ¨Ó¹Ç¹ ò,ðõ÷ ÃÒÂ
- µÍº¤Ó¶ÒÁáÅÐãËé¤Ó»Ã¡ÉÒ´éÒ¹ÂÒ ¨Ó¹Ç¹ õøñ ÃÒÂ
ö.ô
ö.ô
ö.ô ½èÒ¡ÒþÂÒºÒÅ
ö.ô ½èÒ¡ÒþÂÒºÒŽèÒ¡ÒþÂÒºÒÅ
ö.ô ½èÒ¡ÒþÂÒºÒŽèÒ¡ÒþÂÒºÒÅ
ö.ô.ñ ¾Ñ²¹Ò¤Ø³ÀÒ¾§Ò¹ºÃÔËÒäÇÒÁàÊè§
ö.ô.ò ¨Ñ´µÑ駤³Ð¡ÃÃÁ¡ÒþѲ¹ÒÃкº¹Ôà·È·Ò§¡ÒþÂÒºÒÅ
ö.ô.ó ¾Ñ²¹ÒÃٻẺ¡ÒùÔà·È "SRK Clinical Supervision Model"
ö.ô.ô ¨Ñ´·Óâ¤Ã§¡ÒþѲ¹Òá¼¹¡ÒùÔà·È·Ò§¡ÒþÂÒºÒÅ ¼Ùé»èÇ·èÃÑ¡ÉÒ´éÇ HBO
ö.ô.õ â¤Ã§¡ÒÃͺÃÁ¾Ñ²¹Ò¤Ø³ÀÒ¾ºØ¤ÅÒ¡Ã
ö.ô.ö »ÃѺÃٻẺáÅФÙèÁ×Í¡ÒûÃÐàÁÔ¹¡Òúѹ·¡·Ò§¡ÒþÂÒºÒÅ
ö.ô.÷ ¡Ó˹´¡ÒÃãªé Nursing Process 㹡ÅØèÁâäËÅÑ¡
ö.ô.ø ¾Ñ²¹Ò¡Ãкǹ¡Òà áÅФÙèÁ×Í㹡ÒôÙáżÙé»èÇ·èãËéÊÒùéÓ·Ò§ËÅÍ´àÅ×Í´´Ó IV Care CoPs.
ö.ô.ù ¾Ñ²¹Ò KM FA áÅÐá¼¹¡ÒèѴ¡ÒäÇÒÁÃÙéã¹Ë¹èǧҹ
ö.ô.ñð ¨Ñ´¡Ô¨¡ÃÃÁ¡ÒûÃСǴâ¤Ã§¡ÒùÇѵ¡ÃÃÁ·Ò§¡ÒþÂÒºÒÅ

ö.ô.ññ »ÃѺ»ÃاËéͧÃѺ¼Ùé»èÇÂáÅкÃÔËÒáÒÃà¢éÒ¶§ºÃÔ¡ÒÃËéͧ¾ÔàÈÉ
ö.ô.ñò â¤Ã§¡ÒÃàµÃÂÁ¤ÇÒÁ¾ÃéÍÁ¡è͹¡ÒäÅÍ´ Class II
ö.ô.ñó â¤Ã§¡ÒþѲ¹ÒÈÑ¡ÂÀÒ¾¡ÒôÙáżÙé»èÇ·èÃѺ¡ÒüèҵѴËÑÇã¨
ö.ô.ñô â¤Ã§¡ÒûÃÐàÁÔ¹¤Ñ´¡ÃͧáÅÐ LEAN ¡ÒùѴ¼Ùé»èÇ BPH
ö.ô.ñõ â¤Ã§¡ÒûÃÐàÁÔ¹¤Ñ´¡Ãͧ¼Ùé»èÇ¡Ãд١¾Ãع
ö.ô.ñö â¤Ã§¡ÒäѴ¡Ãͧà·éÒã¹¼Ùé»èÇÂá¼ÅàºÒËÇÒ¹
ö.ô.ñ÷ ¾Ñ²¹Òá¹Ç·Ò§¡ÒûÃÐàÁÔ¹ÀÒÇ¡ÒóìËÒÂã¨ÅéÁàËÅÇã¹¼Ùé»èÇ Snack bite
ö.ô.ñø ¨Ñ´·Óá¹Ç·Ò§»¯ÔºÑµÔ¡ÒÃÂ×¹ÂѹµÑǺؤ¤Å ¡Ã³µÒ¼Դ¸ÃÃÁªÒµÔ
ö.õ
ö.õ
ö.õ ½èÒÂʹѺʹع
ö.õ ½èÒÂʹѺʹع½èÒÂʹѺʹع
ö.õ ½èÒÂʹѺʹع½èÒÂʹѺʹع
ö.õ.ñ àǪÃÐàº¹
ñ) ¨Ñ´·Óá¿éÁàǪÃÐàº¹¼Ùé»èÇÂãËÁè ¨Ó¹Ç¹ ôó,òõò àÅèÁ
ò) ºÃÔ¡ÒÃàǪÃÐàº¹¼Ùé»èǹ͡ ¨Ó¹Ç¹ õöö,òöö àÅèÁ
ó) Êèǹ§Ò¹¹Ñ´Åèǧ˹éÒ ¨Ó¹Ç¹ òùõ,õöó àÅèÁ
ô) ºÃÔ¡ÒÃÂ×Á-¤×¹ ¨Ó¹Ç¹ óò,ôöö àÅèÁ
õ) §Ò¹àǪÃÐàº¹¼Ùé»èÇÂã¹ ¨Ó¹Ç¹ òò,õ÷õ àÅèÁ

ÃÒ§ҹ¡Ô¨¡ÒÃÊÒÂá¾·Âì¡Í§·Ñ¾àÃ×Í ñðò
»ÃШӻ§º»ÃÐÁÒ³ òõõù